The Biotech Stage - Brain | heart | eyes

The Biotech Stage - Brain | heart | eyes

Join us for TRI's first Biotech Stage on Tuesday 30th August 2022 from 4:00pm-5:00pm.

By Translational Research Institute (TRI)

Date and time

Tue, 30 Aug 2022 4:00 PM - 5:00 PM AEST

Location

Translational Research Institute

37 Kent Street Woolloongabba, QLD 4102 Australia

About this event

Join us for TRI's first Biotech Stage on Tuesday 30th August 2022 from 4:00pm-5:00pm. This seminar will focus on the brain, heart and eyes and provides an opportunity to connect, hear latest biomedical advances from our newest tenants at TRI, and inspire Researcher – Clinicians - Industry collaborations.

Hear from our three industry speakers:

Mark Smythe, Founder & CEO | Infensa Bioscience: novel drug candidates protecting brain & heart from injury

Dr Brenda Castro, Head of Research | Ocugene: next generation retinal therapeutics and gene delivery vectors

Stuart Newman, CEO | Therapeutics Innovation Australia: Translating research towards the clinic

Date: Tuesday 30th August 2022

Time: 4:00pm-5:00pm

Location: TRI Auditorium & Zoom

Organised by

The Translational Research Institute (TRI) is a leading Australian medical research, development and translation facility. It is home to a broad range of cutting-edge research into cancer, chronic diseases, mental health conditions, immunology, genetics and more. TRI’s priority is partnering scientific development with clinicians and the MedTech sector to ensure new discoveries progress quickly and improve patient outcomes and commercial return. To this end, TRI is at the interface of science, medicine and industry. Our vision is Exceptional Science, Healthier Lives.

Situated on the Princess Alexandra Hospital precinct, TRI is a joint venture between Queensland Health, The University of Queensland, the Queensland University of Technology and Mater Research.

TRI houses more than 1000 leading researchers, support staff and students and has a community of bio-tech and med-tech start-up companies as well as industry bodies located on its campus. The Institute has two clinical trial facilities, one based at the PA Hospital and the other at the Centre for Children’s Health Research next to the Children’s Hospital.

GET INVOLVED

Sales Ended